Ignatius Erlingsson

§1Register entry

§1.1Register entry

Name

Ignatius Erlingsson

Credentials

BPharm, PhD

Role

External reviewer, patient and public involvement

Body

External reviewers

Affiliation

National pharmacovigilance centre

Registered since

2026

Specialism

patient and public involvement

§1.2Declared interests

Declared interests are published in full for every register entry. A declaration is not a disqualification, and the Institute has never given a submission or a review less weight on that ground. The materiality threshold and the recusal rules are set out in the conflicts-of-interest policy, which was settled through public consultation.

§1.3Attribution

External reviewers are named in this register and against their domain rather than against individual documents. A substantial proportion of the reviewer register indicated that per-document attribution would make them less willing to record an objection the assessment committee did not adopt, and the Institute regards a reviewer's willingness to object as more valuable than the incremental accountability of per-document naming. The reasoning is published on the register policy disposition page.